Abstract: Methods of treating a metabolic disorder in a subject are provided. Aspects of the method include administering an effective amount of an N-lactoyl-amino acid to the subject. Also provided are pharmaceutical formulations including an amount of an N-lactoyl-amino acid effective to treat a metabolic disorder. Any suitable N-lactoyl-amino acid or combination of N-lactoyl-amino acids may be administered in the subject methods.

Abstract: A sealant removal composition provided that includes a pyrrolidone solvent, a non-ionic surfactant, and at least one co-solvent. The composition is well suited to removal sulfur-based polymer and silicone-based polymer sealant. A process of removing a sealant from a substrate is provided that includes applying the composition to the sealant. After allowing dwell time for the sealant to swell on the substrate, the sealant is removed.

Abstract: A kiosk for accomplishing device exchange and data transfer includes hardware and software for enabling users to submit a used or damaged device to the kiosk, downloading user information and settings from the submitted device, converting the downloaded user information and settings into an appropriate format for a purchased device, and uploading the converted user information and settings to the purchased device before delivering the purchased device to the user.

Abstract: A concentrated bioenzymatic cleaning product is provided which maintains a homogenous composition under static conditions and does not require shaking or mixing prior to dilution. The concentrated bioenzymatic cleaning product includes bacillus spores, a suspending and/or rheology modifying agent, an odor control agent, a pH adjuster, and water. The types and amounts of ingredients are selected to maintain the bacillus spores in suspension under static conditions, enabling the concentrated bioenzymatic cleaning product to be diluted using a proportioner system.

Abstract: A concentrated bioenzymatic cleaning product is provided which maintains a homogenous composition under static conditions and does not require shaking or mixing prior to dilution. The concentrated bioenzymatic cleaning product includes bacillus spores, a suspending and/or rheology modifying agent, an odor control agent, a pH adjuster, and water. The types and amounts of ingredients are selected to maintain the bacillus spores in suspension under static conditions, enabling the concentrated bioenzymatic cleaning product to be diluted using a proportioner system.

Abstract: A concentrated bioenzymatic cleaning product is provided which maintains a homogenous composition under static conditions and does not require shaking or mixing prior to dilution. The concentrated bioenzymatic cleaning product includes bacillus spores, a suspending and/or rheology modifying agent, an odor control agent, a pH adjuster, and water. The types and amounts of ingredients are selected to maintain the bacillus spores in suspension under static conditions, enabling the concentrated bioenzymatic cleaning product to be diluted using a proportioner system.

Abstract: A concentrated bioenzymatic cleaning product is provided which maintains a homogenous composition under static conditions and does not require shaking or mixing prior to dilution. The concentrated bioenzymatic cleaning product includes bacillus spores, a suspending and/or rheology modifying agent, an odor control agent, a pH adjuster, and water. The types and amounts of ingredients are selected to maintain the bacillus spores in suspension under static conditions, enabling the concentrated bioenzymatic cleaning product to be diluted using a proportioner system.